These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27600335)

  • 41. Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.
    Rahman M; Yang W; Akkina S; Alper A; Anderson AH; Appel LJ; He J; Raj DS; Schelling J; Strauss L; Teal V; Rader DJ;
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1190-8. PubMed ID: 24832097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
    Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
    J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho.
    Kanda E; Ai M; Okazaki M; Yoshida M; Maeda Y
    PLoS One; 2016; 11(11):e0166459. PubMed ID: 27861640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography.
    Whayne TF; Alaupovic P; Curry MD; Lee ET; Anderson PS; Schechter E
    Atherosclerosis; 1981 Jun; 39(3):411-24. PubMed ID: 6942843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of High-Density Lipoprotein Particles and High-Density Lipoprotein Apolipoprotein C-III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi-Ethnic Study of Atherosclerosis.
    Lamprea-Montealegre JA; McClelland RL; Otvos JD; Mora S; Koch M; Jensen MK; de Boer IH
    J Am Heart Assoc; 2019 Dec; 8(24):e013713. PubMed ID: 31818211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
    Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
    Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
    Lanktree MB; Thériault S; Walsh M; Paré G
    Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination.
    Hernáez Á; Soria-Florido MT; Schröder H; Ros E; Pintó X; Estruch R; Salas-Salvadó J; Corella D; Arós F; Serra-Majem L; Martínez-González MÁ; Fiol M; Lapetra J; Elosua R; Lamuela-Raventós RM; Fitó M
    PLoS One; 2019; 14(6):e0218533. PubMed ID: 31246976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?
    Gluba-Brzózka A; Franczyk B; Banach M; Rysz-Górzyńska M
    Int Urol Nephrol; 2017 Jan; 49(1):155-164. PubMed ID: 27942970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteomics of apolipoproteins and associated proteins from plasma high-density lipoproteins.
    Davidsson P; Hulthe J; Fagerberg B; Camejo G
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):156-63. PubMed ID: 19778948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease.
    Marsche G; Heine GH; Stadler JT; Holzer M
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32967334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
    Groener JE; van Gent T; van Tol A
    Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipid levels do not influence the risk of venous thromboembolism. Results of a population-based cohort study.
    van Schouwenburg IM; Mahmoodi BK; Gansevoort RT; Muntinghe FL; Dullaart RP; Kluin-Nelemans HC; Veeger NJ; Meijer K
    Thromb Haemost; 2012 Nov; 108(5):923-9. PubMed ID: 22955992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
    Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R
    Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid abnormalities and oxidized LDL in chronic kidney disease patients on hemodialysis and peritoneal dialysis.
    Samouilidou EC; Karpouza AP; Kostopoulos V; Bakirtzi T; Pantelias K; Petras D; Tzanatou-Exarchou H; J Grapsa E
    Ren Fail; 2012; 34(2):160-4. PubMed ID: 22172020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study.
    Cougnard-Grégoire A; Delyfer MN; Korobelnik JF; Rougier MB; Le Goff M; Dartigues JF; Barberger-Gateau P; Delcourt C
    PLoS One; 2014; 9(3):e90973. PubMed ID: 24608419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.